Skip to content

Clinical trials

Recruiting Prostatic Neoplasms, Castration-Resistant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms, Castration-Resistant Status: Recruiting Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20192
20212
20222
20234
20246
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Janssen Research & Development, LLC2
Merck Sharp & Dohme LLC2
Astellas Pharma Global Development, Inc.1
Bristol-Myers Squibb1
Cancer Research UK1
Celcuity Inc1
Clarity Pharmaceuticals Ltd1
Flare Therapeutics Inc.1
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms, Castration-Resistant24
Prostatic Neoplasms9
Neoplasms6
Genital Diseases, Male3
Male Urogenital Diseases3
Neoplasm Metastasis3
Neoplasms by Site3
Prostatic Diseases3
Colorectal Neoplasms2
Endometrial Neoplasms2

Trials

Showing 76 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.